Cardiorenal Syndrome Type 5: In Vitro Cytotoxicity Effects on Renal Tubular Cells and Inflammatory Profile
Background. Cardiorenal Syndrome Type 5 (CRS Type 5) reflects concomitant cardiac and renal dysfunctions in the setting of a wide spectrum of systemic disorders. Our aim was to study in vitro effects of CRS Type 5 plasma on renal tubular cells (RTCs), in terms of cellular death and the characterizat...
Saved in:
Main Authors: | Alessandra Brocca, Grazia Maria Virzì, Chiara Pasqualin, Silvia Pastori, Stefano Marcante, Massimo de Cal, Claudio Ronco |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2015/469461 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Management of Cardiorenal Syndromes
by: Andrew A. House, et al.
Published: (2011-01-01) -
Cardiovascular and Renal Links along the Cardiorenal Continuum
by: José A. García-Donaire, et al.
Published: (2011-01-01) -
Cardiorenal Syndromes and Sepsis
by: C. Chelazzi, et al.
Published: (2011-01-01) -
The Cardiorenal Syndrome: Making the Connection
by: Gautham Viswanathan, et al.
Published: (2011-01-01) -
Correction of Iron Deficiency in the Cardiorenal Syndrome
by: Donald S. Silverberg, et al.
Published: (2011-01-01)